Europe & Central Asia vs Monaco: Domestic general government health expenditure
Domestic general government health expenditure over time
- Europe & Central Asia
- Monaco
How they compare
Monaco currently reports 85.7% against 73.4% in Europe & Central Asia, a difference of 12.3%.
That makes Monaco's figure about 1.2 times Europe & Central Asia's.
Across all 24 years both countries report, Monaco has been ahead every year.
Europe & Central Asia ranks 4th and Monaco ranks 7th of 47 groups.
Monaco has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Europe & Central Asia | Monaco | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 73.3% | 80.6% | 7.3% | Monaco |
| 2010s | 72.7% | 83.3% | 10.6% | Monaco |
| 2020s | 74.8% | 87.5% | 12.7% | Monaco |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher domestic general government health expenditure, Europe & Central Asia or Monaco?
- Monaco, at 85.7% against 73.4% in Europe & Central Asia as of 2023.
- What is the difference in domestic general government health expenditure between Europe & Central Asia and Monaco?
- 12.3%, with Monaco ahead.
- How many years of comparable data are there for Europe & Central Asia and Monaco?
- 24 years are reported by both, from 2000 to 2023.
- How do Europe & Central Asia and Monaco rank globally for domestic general government health expenditure?
- Europe & Central Asia ranks 4th and Monaco ranks 7th of 47 groups.
- Where does this data come from?
- Global Health Expenditure Database, updated December 12th, 2025, World Health Organization (WHO), published as Domestic general government health expenditure (% of current health expenditure). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Share of current health expenditures funded from domestic public sources for health. Domestic public sources include domestic revenue as internal transfers and grants, transfers, subsidies to voluntary health insurance beneficiaries, non-profit institutions serving households (NPISH) or enterprise financing schemes as well as compulsory prepayment and social health insurance contributions. They do not include external resources spent by governments on health.